These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30193323)

  • 21. Platelet-Derived Growth Factor-BB Enhances Adipogenesis in Orbital Fibroblasts.
    Virakul S; Dalm VA; Paridaens D; van den Bosch WA; Mulder MT; Hirankarn N; van Hagen PM; Dik WA
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5457-64. PubMed ID: 26284551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.
    Zhang C; Zhang X; Ma L; Peng F; Huang J; Han H
    Endocrine; 2012 Apr; 41(2):248-55. PubMed ID: 22237514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory Effects of α-Lipoic Acid on Oxidative Stress-Induced Adipogenesis in Orbital Fibroblasts From Patients With Graves Ophthalmopathy.
    Hwang S; Byun JW; Yoon JS; Lee EJ
    Medicine (Baltimore); 2016 Jan; 95(2):e2497. PubMed ID: 26765462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autophagy is involved in the initiation and progression of Graves' orbitopathy.
    Yoon JS; Lee HJ; Chae MK; Lee EJ
    Thyroid; 2015 Apr; 25(4):445-54. PubMed ID: 25687157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves' Orbitopathy.
    Byeon HJ; Chae MK; Ko J; Lee EJ; Kikkawa DO; Jang SY; Yoon JS
    Invest Ophthalmol Vis Sci; 2023 Aug; 64(11):13. PubMed ID: 37555734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.
    Kumar S; Coenen M; Iyer S; Bahn RS
    Thyroid; 2015 Oct; 25(10):1145-50. PubMed ID: 26213859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cigarette smoke extract-induced adipogenesis in Graves' orbital fibroblasts is inhibited by quercetin via reduction in oxidative stress.
    Yoon JS; Lee HJ; Chae MK; Lee SY; Lee EJ
    J Endocrinol; 2013 Feb; 216(2):145-56. PubMed ID: 23143154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy.
    Zhao P; Deng Y; Gu P; Wang Y; Zhou H; Hu Y; Chen P; Fan X
    Exp Eye Res; 2013 Feb; 107():65-73. PubMed ID: 23219871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of Fatty Acid and Triglyceride Synthesis by the Flavonoid Orientin through Decrease of C/EBPδ Expression and Inhibition of PI3K/Akt-FOXO1 Signaling in Adipocytes.
    Nagai S; Matsumoto C; Shibano M; Fujimori K
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29373533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy.
    Kumar S; Nadeem S; Stan MN; Coenen M; Bahn RS
    J Mol Endocrinol; 2011 Jun; 46(3):155-63. PubMed ID: 21321093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phospholipase C-γ as a Potential Therapeutic Target for Graves' Orbitopathy.
    Roh TH; Chae MK; Ko JS; Kikkawa DO; Jang SY; Yoon JS
    Endocrinol Metab (Seoul); 2023 Dec; 38(6):739-749. PubMed ID: 37989267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy.
    Park HY; Chae MK; Ko J; Kikkawa DO; Jang SY; Yoon JS
    PLoS One; 2022; 17(12):e0279060. PubMed ID: 36521376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin F2α Regulates Adipogenesis by Modulating Extracellular Signal-Regulated Kinase Signaling in Graves' Ophthalmopathy.
    Zhu R; Wang XH; Wang BW; Ouyang X; You YY; Xie HT; Zhang MC; Jiang FG
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of Pathological Features of Graves' Orbitopathy by Activation of Forkhead Transcription Factors, FOXOs.
    Zhang L; Ji QH; Ruge F; Lane C; Morris D; Tee AR; Dayan CM; Ludgate M
    J Clin Endocrinol Metab; 2016 Jan; 101(1):114-22. PubMed ID: 26502358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves' Orbitopathy.
    Schrijver B; Kooiman MA; Kasteleijn E; van Holten-Neelen C; Virakul S; Paridaens D; Peeters RP; van Hagen PM; Dalm VASH; Dik WA
    Thyroid; 2019 Mar; 29(3):395-404. PubMed ID: 30724135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of miR-146a in the Regulation of Inflammation in an In Vitro Model of Graves' Orbitopathy.
    Jang SY; Chae MK; Lee JH; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4027-34. PubMed ID: 27494344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves' orbitopathy.
    Jang SY; Park SJ; Chae MK; Lee JH; Lee EJ; Yoon JS
    Br J Ophthalmol; 2018 Mar; 102(3):407-414. PubMed ID: 29101123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves' ophthalmopathy.
    Kim JY; Park S; Lee HJ; Lew H; Kim GJ
    Stem Cell Res Ther; 2020 Nov; 11(1):469. PubMed ID: 33153489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifibrotic effects of quercetin in primary orbital fibroblasts and orbital fat tissue cultures of Graves' orbitopathy.
    Yoon JS; Chae MK; Jang SY; Lee SY; Lee EJ
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5921-9. PubMed ID: 22871832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sphingosine-1-Phosphate Mediates Fibrosis in Orbital Fibroblasts in Graves' Orbitopathy.
    Ko J; Chae MK; Lee JH; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2017 May; 58(5):2544-2553. PubMed ID: 28492873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.